title: [18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results].
abstract: OBJECTIVE
  Of the present study was to evaluate 18FDG PET as a diagnostic tool in primary and recurrent ovarian cancer.
  
  
  METHODS
  PET of the abdomen and the pelvis was performed in 26 patients suspected for primary (n = 17) or recurrent (n = 9) ovarian cancer with an ECAT 953/15 scanner 45 min after intravenous administration of 245 MBq 18F-FDG (mean). PET findings were validated by surgery, histology and/or cytology.
  
  
  RESULTS
  Ovarian malignancies or recurrent ovarian cancer were demonstrated by PET in 16 out of 19 cases. Malignancy was excluded in six out of seven cases. False negative findings were obtained in two cases of low malignant potential tumors (LMP) and in one case of low grade serous/mucinous ovarian cystadenocarcinoma. PET yielded one false positive result in a case of salpingoophoritis. Quantitative analysis revealed a mean SUV of 6.8 +/- 2.3 in primary ovarian carcinoma vs. 2.6 +/- 1.2 in benign masses (p < 0.05).
  
  
  CONCLUSIONS
  These preliminary data show 18FDG PET to be useful in diagnosis of recurrent ovarian cancer. PET is of limited use in differentiating LMP from benign tumors and ovarian cancer from inflammatory processes. Concerning this differentiation, quantitative analysis does not improve diagnostic accuracy.
authors.affiliation: Klinik für Nuklearmedizin, Universitätsklinikum RWTH Aachen, Deutschland. zimny@nuk-gate.nukmed.rwth-aachen.de
authors.forename: M
authors.initials: M
authors.lastname: Zimny
authors.forename: W
authors.initials: W
authors.lastname: Schröder
authors.forename: S
authors.initials: S
authors.lastname: Wolters
authors.forename: U
authors.initials: U
authors.lastname: Cremerius
authors.forename: W
authors.initials: W
authors.lastname: Rath
authors.forename: U
authors.initials: U
authors.lastname: Büll
mesh_terms: D000328:Adult; D000368:Aged; D003536:Cystadenocarcinoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D019275:Radiopharmaceuticals; D012008:Recurrence; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18